This proposal is, at least in part, supported by animal model studies: mice in which ASPH is deleted develop defects, which in part reflect symptoms of Traboulsi syndrome patients, although ocular phenotypes were not observed (31). The gene discussed is ASPH; the disease is facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome.